We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic-Drug Makers May Remove REMS Under Final FDA Guidance
Generic-Drug Makers May Remove REMS Under Final FDA Guidance
December 6, 2011
A final FDA guidance allows generic-drug makers to remove a drug’s risk evaluation and mitigation strategy (REMS) if the reference drug’s REMS has been removed.